A detailed history of Pfs Investments Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Pfs Investments Inc. holds 23,563 shares of BIIB stock, worth $4.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
23,563
Previous 23,737 0.73%
Holding current value
$4.1 Million
Previous $6.81 Million 1.41%
% of portfolio
0.11%
Previous 0.12%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$275.25 - $318.06 $47,893 - $55,342
-174 Reduced 0.73%
23,563 $6.71 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $129,306 - $147,339
504 Added 2.17%
23,737 $6.81 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $577,077 - $701,161
-2,286 Reduced 8.96%
23,233 $6.43 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $255,043 - $351,682
-1,310 Reduced 4.88%
25,519 $6.81 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $427,028 - $507,816
-2,277 Reduced 7.82%
26,829 $5.47 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $83,902 - $105,712
-433 Reduced 1.47%
29,106 $6.13 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $43,664 - $56,115
195 Added 0.66%
29,539 $7.09 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $45,278 - $59,048
-160 Reduced 0.54%
29,344 $8 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $728,567 - $1.17 Million
2,813 Added 10.54%
29,504 $10.6 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $1.11 Million - $1.3 Million
4,576 Added 20.69%
26,691 $7.47 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $813,915 - $1.23 Million
3,445 Added 18.45%
22,115 $5.92 Million
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $630,682 - $728,201
2,382 Added 14.62%
18,670 $5.3 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $619,232 - $820,064
2,394 Added 17.23%
16,288 $4.36 Million
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $796,333 - $1.01 Million
2,962 Added 27.09%
13,894 $4.4 Million
Q4 2019

Feb 12, 2020

BUY
$220.06 - $304.07 $333,610 - $460,970
1,516 Added 16.1%
10,932 $3.24 Million
Q3 2019

Nov 05, 2019

BUY
$217.44 - $243.88 $717,552 - $804,804
3,300 Added 53.96%
9,416 $2.19 Million
Q2 2019

Jul 10, 2019

BUY
$219.29 - $241.72 $913,562 - $1.01 Million
4,166 Added 213.64%
6,116 $1.43 Million
Q1 2019

Apr 05, 2019

BUY
$216.71 - $338.96 $422,584 - $660,972
1,950 New
1,950 $461,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Pfs Investments Inc. Portfolio

Follow Pfs Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.